Fonterra mulls options - sale or IPO
An outright sale of Fonterra’s global consumer business is more likely than a float, says Forsyth Barr senior analyst equities, Matt Montgomerie.
Fonterra has pulled the plug on its joint venture in India.
Fonterra Future Dairy was launched in 2018 as a 50:50 joint venture between the co-operative and Future Consumer Ltd.
It launched a range of consumer products made from Indian milk and distributed Anchor Food Professionals products for the foodservice sector.
Fonterra chief executive for the Asia Pacific region Judith Swales says the last few years have been challenging for the joint venture with Covid disrupting to the Indian market.
Swales says despite this the joint venture has delivered some important initiatives, including the launch of the Dreamery brand. She says the brand received positive feedback from consumers.
Future Consumer is the fast moving consumer goods (FMCG) arm of the Future Group. According to media reports out of India, the debt-laden company was told by regulators to sell 200 of its 1,700 retail outlets.
Fonterra's exit from the joint venture is unlikely to impact its balance sheet. "The co-op entered the joint venture as a capital-light way to test the Indian market, which has a large dairy consuming population but restrictive trade access for New Zealand dairy," says Swales.
"We will continue to have a presence in India through Anchor Food Professionals and our Ingredients business, and will explore opportunities to grow access for our New Zealand milk as they come up."
The 22 people employed by the joint venture will receive appropriate entitlements, says Swales.
New Zealand's red meat exports for 2024 finished on a positive note, with total export value increasing 17% over last December to reach $1.04 billion, according to the Meat Industry Association (MIA).
One of the most important events in the history of the primary sector that happened 143 years ago was celebrated in style at Parliament recently.
Many companies are financially mortally wounded by the effects of Cyclone Gabrielle and may have to sell up because of their high debt levels.
AgResearch scientists have collected the first known data showing behavioural developmental impacts on lambs whose mothers were treated with long-acting drugs for parasites.
Biosecurity New Zealand Commissioner, North, Mike Inglis says the $2.4 million cost of a recent biosecurity operation in South Auckland is small compared to the potential economic impact of an incursion.
Primary sector groups appear to be generally supportive of the Gene Technology Bill currently before parliamentarians.
OPINION: Australian dairy is bracing for the retirement of an iconic dairy brand.
OPINION: Another sign that the plant-based dairy fallacy is unravelling and that nothing beats dairy-based products.